Abstract
Background and aims
Methods
Results
Conclusions
Keywords
1. Introduction
- Remuzzi A.
- Remuzzi G.
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html. Last accessed March 29, 2020.
- Gu J.
- Han B.
- Wang J.
- Xiao F.
- Tang M.
- Zeng X.
- et al.
- Repici A.
- Maselli R.
- Colombo M.
- et al.
- Hussain A.
- Singhal T.
- El-Hasani S.
2. Background
- Galloro G.
- Pisani A.
- Zagari R.C.
- et al.
3. Methods
3.1 Study design and participants
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report. https://www.who.int/emergencies/diseases/novel-coronavirus 2019?gclid=EAIaIQobChMIqIz7mMen6gIVDxsYCh3dYQ35EAAYASAAEgKYtvD_BwE. last accessed June29, 2020.
3.2 Statistical analysis
4. Results
4.1 Characteristics of the participating endoscopy centers

Endoscopy Centers, n = 201 n. (%) | |
---|---|
Participants per center, n | |
1 | 124 (61.7) |
2 | 54 (26.9) |
3 | 15 (7.5) |
4 | 3 (1.5) |
5 | 5 (2.5) |
Geographic macro-area | |
North-West | 56 (27.9) |
North-East | 44 (21.9) |
Center | 41 (20.4) |
South and Islands | 60 (29.8) |
Hospital setting | |
Community hospital | 139 (69.2) |
University hospital | 33 (16.4) |
Private hospital | 29 (14.4) |
Involvement of HCWs in a COVID-19 team | |
No | 123 (61.2) |
Yes | 78 (38.8) |
4.2 Changes in endoscopy practice
4.3 Use of precautions for healthcare workers
Total | Geographic macroarea | |||||
---|---|---|---|---|---|---|
North West | North East | Center | South and Islands | |||
Endoscopy center, n. | 201 | 56 | 44 | 41 | 60 | |
n (%) | n (%) | n (%) | n (%) | n (%) | p value | |
Use of surgical mask: | ||||||
For suspected and COVID-19 patients | 4 (2) | 1 (1.8) | 0 | 1 (2.4) | 2 (3.3) | |
For all patients | 186 (92.5) | 52 (92.9) | 42 (95.5) | 38 (92.7) | 54 (90) | |
No availability of surgical masks | 11 (5.5) | 3 (5.4) | 2 (4.5) | 2 (4.9) | 4 (6.7) | 0.94 |
Use of FFP2 or FFP3 masks: | ||||||
For suspected and COVID-19 patients | 83 (41.3) | 19 (33.9) | 17 (38.6) | 21 (51.2) | 26 (43.3) | |
For all patients | 96 (47.8) | 36 (64.3) | 22 (50) | 17 (41.5) | 21 (35) | |
No availability of FFP2 and FFP3 | 22 (10.9) | 1 (1.8) | 5 (11.4) | 3 (7.3) | 13 (21.7) | 0.03 |
Use of googles or facial screens: | ||||||
For suspected and COVID-19 patients | 32 (15.9) | 5 (8.9) | 7 (15.9) | 6 (14.6) | 14 (23.3) | |
For all patients | 165 (82.1) | 51 (91.1) | 37 (84.1) | 33 (80.5) | 44 (73.3) | |
No availability of googles or screen | 4 (2) | 0 | 0 | 2 (4.9) | 2 (3.3) | 0.22 |
Use of disposable water repellent gown: | ||||||
For suspected and COVID-19 patients | 31 (15.4) | 9 (16.1) | 4 (9.1) | 9 (22) | 9 (15.0) | |
For all patients | 157 (78.1) | 46 (82.1) | 38 (86.4) | 29 (70.7) | 44 (73.3) | |
No availability of disposable water repellent gown | 13 (6.5) | 1 (1.8) | 2 (4.5) | 3 (7.3) | 7 (11.7) | 0.24 |
Use of double glove: | ||||||
Only for COVID-19 positive patients | 10 (5.1) | 3 (5.4) | 1 (2.3) | 2 (4.9) | 4 (6.8) | |
For suspected and COVID-19 patients | 62 (31.2) | 12 (21.5) | 13 (30.2) | 13 (31.7) | 24 (40.7) | |
For all patients | 137 (68.8) | 44 (78.6) | 30 (69.8) | 28 (68.3) | 35 (59.3) | 0.41 |
Availability of a negative pressure room | ||||||
No | 151 (75.1) | 40 (71.4) | 28 (63.6) | 35 (85.4) | 48 (80) | |
Yes | 50 (24.9) | 16 (28.6) | 16 (36.4) | 6 (14.6) | 12 (20) | 0.18 |
Were training courses for dressing and undressing, including use of personal protective equipment, performed in the last 4 weeks for endoscopy staff (doctors, nurses, etc.) ? | ||||||
No | 86 (42.8) | 20 (35.7) | 14 (31.8) | 14 (34.1) | 38 (63.3) | |
Yes | 118 (57.2) | 36 (64.3) | 30 (68.2) | 27 (65.9) | 22 (36.7) | 0.002 |
4.4 Use of precautions for patients
4.5 SARS-CoV-2 infection among health care workers
Endoscopy center, n. | Total | North West | North East | Center | South and Islands | |
---|---|---|---|---|---|---|
201 | 56 | 44 | 41 | 60 | ||
n (%) | n (%) | n (%) | n (%) | n (%) | p value | |
Occurrence of at least one healthcare worker (physicians, nurses, etc.) with positive COVID-19 swab in the center. | ||||||
No | 166 (82.1) | 38 (67.8) | 34 (77.2) | 36 (87.8) | 58 (96.7) | |
Yes | 35 (17.4) | 18 (32.2) | 10 (22.7) | 5 (12.2) | 2 (3.3) | 0.002 |
Occurrence of at least one physician with positive COVID-19 swab in the center. | ||||||
0 | 177 (88.1) | 44 (78.6) | 37 (84.1) | 37 (90.2) | 59 (98.3) | |
1–4 | 24 (11.9) | 12 (21.4) | 7 (15.9) | 4 (9.8) | 1 (1.7) | 0.01 |
Occurrence of at least one nurse with positive COVID-19 swab in the center. | ||||||
0 | 170 (85) | 38 (67.9) | 38 (86.4) | 36 (90) | 58 (96.7) | |
1–4 | 30 (15) | 18 (32.2) | 6 (13.6) | 4 (10) | 2 (3.3) | 0.001 |
Occurrence of at least one other health operator with positive COVID-19 swab in the center. | ||||||
0 | 191 (95) | 51 (91.1) | 42 (95.4) | 40 (97.6) | 58 (96.7) | |
1–4 | 10 (5) | 5 (8.9) | 2 (4.6) | 1 (2.4) | 2 (3.3) | 0.43 |
In case of contact with a COVID-19 positive HCW did healthcare professionals or patients undergo COVID-19 swab screening? | ||||||
No | 89 (46.1) | 34 (61.8) | 13(32.5) | 21 (51.2) | 21 (36.8) | |
Yes | 71 (36.8) | 13 (23.6) | 19 (47.5) | 15 (36.6) | 24 (42.1) | |
Only in those operators with | ||||||
suspected COVID-19 symptoms | 33 (17.1) | 8 (14.6) | 8 (20) | 5 (12.2) | 12 (21.1) | 0.07 |
Centers with positive healthcare workers | |||
---|---|---|---|
Investigated factors | Non = 145 | yes n = 35 | |
n (%) | n (%) | OR (95% CI) | |
Geographic macro-area | |||
North-West | 34 (23.5) | 18 (51.4) | 1.0 |
North-East | 28 (19.3) | 10 (28.6) | 0.95 (0.34–2.65) |
Center | 34 (23.5) | 5 (14.3) | 0.51 (0.15–1.72) |
South and Islands | 49 (33.8) | 2 (5.7) | 0.13 (0.25–0.63) |
Practice setting | |||
Community hospital | 103 (71) | 25 (71.4) | 1.0 |
University hospital | 21 (14.5) | 7 (20) | 1.18 (0.40–3.51) |
Private clinic | 21 (14.5) | 3 (8.6) | 0.54 (0.13–2.21) |
Involvement of HCWs in a COVID-19 team | |||
No | 99 (68.3) | 9 (25.7) | 1.0 |
Yes | 46 (31.7) | 26 (74.3) | 4.96 (1.97–12.51) |
Availability of a negative pressure room | |||
No | 111 (76.6) | 23 (65.7) | 1.0 |
Yes | 34 (23.5) | 12 (34.3) | 1.40 (0.54–3.63) |
Training courses for dressing and undressing PPEs | |||
Yes | 88 (60.7) | 19 (54.3) | 1.0 |
No | 57 (39.3) | 16 (45.7) | 2.65 (1.07–6.53) |
Use of FFP2 or FFP3 masks for all patients | |||
Yes | 67 (46.2) | 24 (68.6) | 1.0 |
No | 78 (53.8) | 11 (31.4) | 0.52 (0.21–1.30) |
5. Discussion
- Galloro G.
- Pisani A.
- Zagari R.C.
- et al.
- Repici A.
- Pace F.
- Gabbiadini R.
- et al.
- Capurso G.
- Archibugi L.
- Vanella G.
- Verbeek J.H.
- Rajamaki B.
- Ijaz S.
- et al.
- Abdelrahim M.
- Hossain E.
- Subramaniam S.
- Bhandari P.
- Rutter M.D.
- Brookes M.
- Lee T.J.
- Rogers P.
- Sharp L.
- Manes G.
- Repici A.
- Radaelli F.
- Bezzio C.
- Colombo M.
- Saibeni S.
Study contribution
Declaration of Competing Interest
Acknowledgments
Funding information
Appendix. Supplementary materials
References
- COVID-19 and Italy: what next?.Lancet. 2020; 395 (Apr 11Epub 2020 Mar 13.PMID:32178769): 1225-1228https://doi.org/10.1016/S0140-6736(20)30627-9
- Covid-19: Italy confirms 11 deaths as cases spread from north.BMJ. 2020; 368 (Feb 26): m757https://doi.org/10.1136/bmj.m757
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html. Last accessed March 29, 2020.
- COVID-19: gastrointestinal manifestations and potential fecal-oral transmission.Gastroenterology. 2020; (Mar 3pii: S0016-5085(20)30281-X. [Epub ahead of print])https://doi.org/10.1053/j.gastro.2020.02.054
- Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: a working hypothesis.Gastroenterology. 2020; 159: 81-95https://doi.org/10.1053/j.gastro.2020.03.065
- Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis.Dig Liver Dis. 2020; 52: 1383-1389https://doi.org/10.1016/j.dld.2020.09.009
- Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology. 2020; (Mar 3pii: S0016-5085(20)30282-1. [Epub ahead of print])https://doi.org/10.1053/j.gastro.2020.02.055
- Coronavirus (COVID-19) outbreak: what the department of endoscopy should know.Gastrointest Endosc. 2020; (March[Epub ahead of print])https://doi.org/10.1016/j.gie.2020.03.019
- Extent of infectious SARS-CoV-2 aerosolisation as a result of oesophagogastroduodenoscopy or colonoscopy.Br J Hosp Med. 2020; 81 (Lond).Jul 2Epub 2020 Jul 6. PMID:32730160: 1-7https://doi.org/10.12968/hmed.2020.0348
- ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic.Endoscopy. 2020; 52: 891-898https://doi.org/10.1055/a-1213-5761
- AGA institute rapid recommendations for gastrointestinal procedures during the COVID-19 Pandemic.Gastroenterology. 2020; 159: 739-758.e4https://doi.org/10.1053/j.gastro.2020.03.072
- Safety in digestive endoscopy procedures in the COVID era recommendations in progress of the Italian society of digestive endoscopy.Dig Liver Dis. 2020; (May 13[Epub ahead of print])https://doi.org/10.1016/j.dld.2020.05.002
- Low risk of covid-19 transmission in GI endoscopy.Gut. 2020; 0: 1-3https://doi.org/10.1136/gutjnl-2020-321341
- Factors associated with the risk of patients and health care workers to develop COVID-19 during digestive endoscopy in a high-incidence area.Gastrointest Endosc. 2020; 93: 274-275https://doi.org/10.1016/j.gie.2020.07.019
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report. https://www.who.int/emergencies/diseases/novel-coronavirus 2019?gclid=EAIaIQobChMIqIz7mMen6gIVDxsYCh3dYQ35EAAYASAAEgKYtvD_BwE. last accessed June29, 2020.
- Fast track endoscopy study group. Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy.Dig Liver Dis. 2020; 52 (Jul): 695-699
- Endoscopic units and the COVID-19 outbreak: a multi-center experience from Italy.Gastroenterology. 2020; (Apr 10pii: S0016-5085(20)30466-2[Epub ahead of print])https://doi.org/10.1053/j.gastro.2020.04.003
- Infection control practices and outcomes of endoscopy units in the Lombardy region of Italy: a survey from the Italian society of digestive endoscopy during COVID-19 spread.J Clin Gastroenterol. 2020; (in press)https://doi.org/10.1097/MCG.0000000000001440
- Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.Cochrane Database Syst Rev. 2019; 7 (Published 2019 Jul 1)CD011621https://doi.org/10.1002/14651858.CD011621.pub3
- Essentials of donning, doffing, and changes in endoscopy practice to reduce the risk of spreading COVID-19 during endoscopy.VideoGIE. 2020; 5 (Jun 29PMID:32821862; PMCID: PMC7323670): 332-334https://doi.org/10.1016/j.vgie.2020.04.013
- Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a national endoscopy database analysis.Gut. 2020; (Jul 20gutjnl-2020-322179Epub ahead of print. PMID:32690602; PMCID:PMC7385747)https://doi.org/10.1136/gutjnl-2020-322179
- Impact of the COVID-19 pandemic on gastrointestinal endoscopy activity in France.Endoscopy. Dec 2020; 52: 1111-1115
- Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: an exit strategy with a lot of critical issues and a few opportunities.Dig Liver Dis. 2020; 52 (AugEpub 2020 Jun 19. PMID:32605868; PMCID: PMC7303656): 823-828https://doi.org/10.1016/j.dld.2020.05.042